Compound details
Canavanine
| Compound ID | CDAMM00773 |
|---|---|
| Common name | Canavanine | IUPAC name | 2-amino-4-(diaminomethylideneamino)oxybutanoic acid |
| Molecular formula | C5H12N4O3 |
| Retention time | 0.44 |
|---|---|
| Adduct | [M+K]+ |
| Actual mz | 215.057 | Theoretical mz | 215.054 |
| Error | 12.75 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.0162 |
| Inchi key | FSBIGDSBMBYOPN-VKHMYHEASA-N |
|---|---|
| Smiles | O=C(O)C(N)CCONC(=N)N |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SEA |
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SwissTargetPrediction and SEA |
| P29474 | NOS3 | Nitric-oxide synthase, endothelial | T06046 | SEA |
| P09960 | LTA4H | Leukotriene A4 hydrolase | T03691 | SEA |
| O00222 | GRM8 | Metabotropic glutamate receptor 8 | T77548 | SEA |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P43005 | SLC1A1 | Excitatory amino acid transporter 3 | T31721 | SEA |
| P39086 | GRIK1 | Glutamate receptor ionotropic kainate 1 | T73495 | SEA |
| Q13002 | GRIK2 | Glutamate receptor ionotropic kainate 2 | T58178 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| Q16478 | GRIK5 | Glutamate receptor ionotropic kainate 5 | T87930 | SEA |
| Q13003 | GRIK3 | Glutamate receptor ionotropic kainate 3 | T68876 | SEA |
| Q9H4A4 | RNPEP | Aminopeptidase B | T57818 | SEA |
| Q01650 | SLC7A5 | L-type amino acid transporter 1 (by homology) | T48330 | SEA |
| Q9ULA0 | DNPEP | Aspartyl aminopeptidase | T45287 | SEA |
| P05089 | ARG1 | Arginase-1 (by homology) | T63224 | SwissTargetPrediction and SEA |
| P00480 | OTC | Ornithine transcarbamylase | T52098 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T06046 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P29474 | NOS3 |
| T03691 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P09960 | LTA4H |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T73495 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P39086 | GRIK1 |
| T73495 | DI0396 | Substance abuse | [ICD-11: 6C40] | P39086 | GRIK1 |
| T45287 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q9ULA0 | DNPEP |
| T63224 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P05089 | ARG1 |
| T52098 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P00480 | OTC |